NSE · Healthcare · Drug Manufacturers - General
| Holder | Stake |
|---|---|
| Jupiter India Fund | 1.52% |
| Investor Education and Protection Fund Authority | 1.09% |
| Equity Intelligence India | 1.01% |
| Document | Date |
|---|---|
| Quarterly results · Q1 FY27 TTK HEALTHCARE LIMITED – Q1 FY2026-27 FINANCIAL SUMMARY HEADLINE NUMBERS • Q1 Revenue from Operations: Rs 25,755.76 lakhs (vs Rs 21,794.47 lakhs in | 2026-08-06 |
| Annual report FY2026 TTK HEALTHCARE LIMITED – ANNUAL REPORT 2025-26 SUMMARY FOR RETAIL INVESTORS --- HEADLINE NUMBERS • Revenue from Operations (Continuing Operations): | 2026-06-27 |
| Quarterly results · Q4 FY26 TTK HEALTHCARE LIMITED – FINANCIAL RESULTS SUMMARY Year Ended March 31, 2026 --- HEADLINE NUMBERS • Revenue from Operations (FY2026): Rs. 85,728.11 | 2026-05-30 |
| Quarterly results · Q3 FY26 TTK HEALTHCARE LIMITED – FINANCIAL SUMMARY Q3 FY2025-26 (Quarter & 9-Month Period Ended December 31, 2025) --- HEADLINE NUMBERS • Q3 Revenue from O | 2026-01-22 |
| Quarterly results · Q2 FY26 TTK HEALTHCARE LIMITED – FINANCIAL SUMMARY Q2 FY2025-26 (Half-Year Ended September 30, 2025) --- HEADLINE NUMBERS • Total Income (H1): Rs 42,999.75 | 2025-10-17 |
| Quarterly results · Q1 FY26 TTK HEALTHCARE LIMITED - Q1 FY2025-26 SUMMARY HEADLINE NUMBERS • Revenue from Operations: Rs 22,642.98 lakhs (Q1 FY26) vs Rs 20,790.21 lakhs (Q1 FY2 | 2025-08-04 |
| Annual report FY2025 | 2025-06-27 |
| Quarterly results | 2025-01-24 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹10 / share ex-date Jul 17, 2026 | 2026-07-17 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for TTK Healthcare Limited — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.